Remove Acquisition Remove Company Remove Develop Remove Thousand Oaks
article thumbnail

Teledyne Completes $789M e2v Acquisition

socalTECH

Thousand Oaks-based Teledyne Technologies Incorporated and UK-based e2v technologies plc said today that the two have completed the $789M acquisition of e2v by Teledyne. e2v develops machine vision products, including image sensors and custom cameras and applications. The deal had been announced in December.

article thumbnail

Amgen Completes Five Prime Therapeutics Deal

socalTECH

Thousand Oaks-based Amgen said this morning that it has successfully completed its $1.9 billion acquisition of Five Prime Therapeutics, a clinical-stage biotechnology company focused on developing immuno-oncology and targeted cancer therapies. Amgen paid $38.00 per share in cash for Five Prime Therapeutics.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Amgen Takes Stake In Chinese Oncology Company

socalTECH

Thousand Oaks-based Amgen said on Thursday afternoon that it has taken a 20.5 percent stake in BeiGene , a research-based, oncology-focused biotechnology company in China. BeiGene has a 700-person commercial organization and 600-person clinical development organization, according to Amgen. READ MORE>>.

article thumbnail

Teledyne Acquires ChartWorld

socalTECH

Thousand Oaks-based Teledyne Technologies said on Tuesday that it has acquired ChartWorld International. ChartWorld is based in Headquarters, and develops digital marine navigation hardware and software. The company also has lactions in Hamburg, Singapore, Vancouver and Tokyo.

article thumbnail

Teledyne Buys Falcon Analytical Systems

socalTECH

Thousand Oaks-based Teledyne Technologies has acquired Falcon Analytics Systems & Technologies , a West Virginia-based developer of compact, rugged gas chromatographs (GC) for industrial process control, industrial laboratory and transportable GC applications, the company said this morning. READ MORE>>.

article thumbnail

Amgen Acquires Teneobio For $900M

socalTECH

Thousand Oaks-based Amgen said on Tuesday that it will pay $900M for Teneobio, a biopharmaceuticals company which is developing treatments for patients with cancer. According to Amgen, the all cash $900M deal also includes future contingent milestone payments worth up to an additional $1.6 billion in cash.

article thumbnail

Amgen Acquires Rodeo Therapeutics

socalTECH

Thousand Oaks-based Amgen and Rodeo Therapeutics Corporation announced late Tuesday that Amgen has agreed to acquire Rodeo, a Seattle-based biopharmaceuticals company which is developing small molecule therapies to promote regeneration and repair of multiple tissues.